The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
PrEP, undetectable, on treatment … what does it all mean? Here we give you a quick run through in our jargon-busting blog.
New research marks welcome step to make trans women in sub-Saharan Africa visible in HIV data.
Language matters. Changing how people who use drugs are treated requires changing how we speak about them.
A US trial among 15 to 17 year-old men who have sex with men (MSM) suggests this group stands to benefit hugely should pre-exposure prophylaxis (PrEP) be approved – and supported – for this age group.
A ground-breaking review provides stark evidence of the damage criminalisation has on preventing and treating HIV among people who inject drugs.
A study of gay men in Malawi reveals very low levels of HIV testing and treatment access nationwide – with distinct geographic disparities in HIV prevalence that need to be taken into consideration and addressed.
The UNODC highlights disease burden, increased opioid abuse and a lack of treatment access in their global state of drug use report.
Disturbing patterns of mistreatment, discrimination, violence and harassment, with knock-on impacts on health and HIV risk, have been revealed by the largest ever survey of transgender people living in the United States of America (USA).
Reducing the number of age-disparate relationships in east and southern Africa could help to decrease HIV infection rates among young women in the region.
Trans women and gay men in Myanmar experience stigma and discrimination making them unlikely to access HIV services – HIV self-testing can help fill the HIV testing gap.